P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO Volume : 5 Issue : 2 Year : 2021
Eurasian Journal of Medicine and Oncology

Volume: 5 Issue: 2 - 2021

REVIEW
Silver Nanoparticles – A Review
Amica Panja, Ashish Kumar Mishra, Mahesh Dash, Narendra Kumar Pandey, Sachin Kumar Singh, Bimlesh Kumar
doi: 10.14744/ejmo.2021.59602   Pages  95 -  102 
(Viewed: 25 / Downloaded: 19)

Role of Gut Microbiota in Pathogenesis and Treatment of Type 2 Diabetes
Navneet Duggal, Sumir Kapoor
doi: 10.14744/ejmo.2021.56223   Pages  103 -  110 
(Viewed: 11 / Downloaded: 10)

RESEARCH ARTICLE
Adjuvant Chemoradiotherapy for Gastric Tumors with D2 Dissection: A Controversial Problem
Ibrahim Karadag, Serdar Karakaya, Ozturk Ates, Berna Cakmak Oksuzoglu
doi: 10.14744/ejmo.2021.49333   Pages  111 -  116 
(Viewed: 8 / Downloaded: 4)

Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma
Cagri Oner, Ertugrul Colak
doi: 10.14744/ejmo.2021.65874   Pages  117 -  122 
(Viewed: 4 / Downloaded: 4)

Forecasting COVID-19 Cases in Egypt Using ARIMA-Based Time-Series Analysis
Ibrahim Sabry, Mohamed ElWakil, Amir Hussain Idrisi, Abdel-Hamid Ismail Mourad
doi: 10.14744/ejmo.2021.64251   Pages  123 -  131 
(Viewed: 8 / Downloaded: 6)

Evaluation of Parametric Method Performance for Left-Censored Data and Recommendation of Using for Covid-19 Data Analysis
Mustafa Agah Tekindal, Harun Yonar, Saadet Kader
doi: 10.14744/ejmo.2021.90258   Pages  132 -  143 
(Viewed: 6 / Downloaded: 6)

Ejmo Scholarone
EJMO has been indexed in web of science
( Emerging Sources Citation Index)
EJMO Citations
Number of Citations: 1017
Number of Articles: 223
Accept Ratio : 31.8 %

Avg. days from submission to first decision 25.3

Avg. days from submission to final decision 26.5

EJMO NLM ID: 101720527
Our Other Journal EJMI
EJMO & EJMO